Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.

Ruan X, Neubauer H, Yang Y, Schneck H, Schultz S, Fehm T, Cahill MA, Seeger H, Mueck AO.

Climacteric. 2012 Oct;15(5):467-72. doi: 10.3109/13697137.2011.648232. Epub 2012 Feb 15.

PMID:
22335423
2.

The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.

Neubauer H, Yang Y, Seeger H, Fehm T, Cahill MA, Tong X, Ruan X, Mueck AO.

Menopause. 2011 Aug;18(8):845-50. doi: 10.1097/gme.0b013e31820e5ac5.

PMID:
21532513
3.

Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.

Neubauer H, Ruan X, Schneck H, Seeger H, Cahill MA, Liang Y, Mafuvadze B, Hyder SM, Fehm T, Mueck AO.

Menopause. 2013 May;20(5):504-10. doi: 10.1097/GME.0b013e3182755c97.

PMID:
23615641
4.
5.

Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.

Schneck H, Ruan X, Seeger H, Cahill MA, Fehm T, Mueck AO, Neubauer H.

Gynecol Endocrinol. 2013 Feb;29(2):160-3. doi: 10.3109/09513590.2012.730572. Epub 2012 Nov 2.

PMID:
23116217
6.

Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.

Neubauer H, Adam G, Seeger H, Mueck AO, Solomayer E, Wallwiener D, Cahill MA, Fehm T.

Climacteric. 2009 Jun;12(3):230-9. doi: 10.1080/13697130802635637.

PMID:
19340614
7.

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.

Zhou J, Yu Q, Chen R, Seeger H, Fehm T, Cahill MA, Mueck AO, Neubauer H.

Maturitas. 2013 Oct;76(2):129-33. doi: 10.1016/j.maturitas.2013.06.013. Epub 2013 Jul 12.

PMID:
23856385
8.

New insight on a possible mechanism of progestogens in terms of breast cancer risk.

Neubauer H, Chen R, Schneck H, Knorrp T, Templin MF, Fehm T, Cahill MA, Seeger H, Yu Q, Mueck AO.

Horm Mol Biol Clin Investig. 2011 Apr 1;6(1):185-92. doi: 10.1515/HMBCI.2010.082.

PMID:
25961254
10.

Possible role of PGRMC1 in breast cancer development.

Neubauer H, Ma Q, Zhou J, Yu Q, Ruan X, Seeger H, Fehm T, Mueck AO.

Climacteric. 2013 Oct;16(5):509-13. doi: 10.3109/13697137.2013.800038. Epub 2013 Jun 12. Review.

PMID:
23758160
11.

Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells.

Ruan X, Schneck H, Schultz S, Fehm T, Cahill MA, Seeger H, Chen R, Yu Q, Mueck AO, Neubauer H.

Gynecol Endocrinol. 2012 Nov;28(11):863-6. doi: 10.3109/09513590.2012.671396. Epub 2012 Apr 12.

PMID:
22494101
12.

Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.

Chen FP, Chien MH, Chen HY, Huang TS, Ng YT.

Taiwan J Obstet Gynecol. 2013 Sep;52(3):365-73. doi: 10.1016/j.tjog.2012.09.038.

14.

The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.

Krämer EA, Seeger H, Krämer B, Wallwiener D, Mueck AO.

Eur J Obstet Gynecol Reprod Biol. 2006 Nov;129(1):77-83. Epub 2006 Feb 7.

PMID:
16460873
16.
18.

Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.

Seeger H, Wallwiener D, Mueck AO.

Gynecol Endocrinol. 2008 Oct;24(10):576-9. doi: 10.1080/09513590802288267.

PMID:
19012101
20.

Progestin regulation of vascular endothelial growth factor in human breast cancer cells.

Hyder SM, Murthy L, Stancel GM.

Cancer Res. 1998 Feb 1;58(3):392-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk